Luigi Naldini
Founder at GENENTA SCIENCE S.P.A.
Net worth: 4 M $ as of 2024-04-29
Luigi Naldini active positions
Companies | Position | Start | End |
---|---|---|---|
GENENTA SCIENCE S.P.A. | Founder | 2014-07-23 | - |
Corporate Officer/Principal | 2014-07-23 | - | |
San Raffaele-Telethon Institute for Gene Therapy | Director/Board Member | - | - |
Università Vita-Salute San Raffaele | Corporate Officer/Principal | - | - |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Director/Board Member | - | - |
Career history of Luigi Naldini
Former positions of Luigi Naldini
Companies | Position | Start | End |
---|---|---|---|
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Founder | - | - |
European Society of Gene & Cell Therapy | President | - | - |
GeneSpire Srl
GeneSpire Srl BiotechnologyHealth Technology GeneSpire Srl is a holding company, which engages in the development of transformative gene therapies for patients with genetic diseases. The company was founded by Luigi Naldini and Alessio Cantone in March 2020 and is headquartered in Milan, Italy. | Founder | 2020-02-29 | - |
Epsilen Bio Srl
Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Epsilen Bio SRL operates as a biotechnology company. It develops novel therapies based on epigenetic silencing. The company was founded by Angelo Lombardo and Luigi Naldini in December 2019 and is headquartered in Milan, Italy. | Founder | 2019-11-30 | - |
MAGENTA THERAPEUTICS | Founder | 2015-06-16 | - |
Training of Luigi Naldini
University of Turin | Doctorate Degree |
Università degli Studi di Roma Tor Vergata | Doctorate Degree |
Statistics
International
Italy | 8 |
United States | 4 |
Belgium | 2 |
Operational
Founder | 5 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Sectoral
Health Technology | 6 |
Consumer Services | 4 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
GENENTA SCIENCE S.P.A. | Health Technology |
Private companies | 7 |
---|---|
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
San Raffaele-Telethon Institute for Gene Therapy | |
GeneSpire Srl
GeneSpire Srl BiotechnologyHealth Technology GeneSpire Srl is a holding company, which engages in the development of transformative gene therapies for patients with genetic diseases. The company was founded by Luigi Naldini and Alessio Cantone in March 2020 and is headquartered in Milan, Italy. | Health Technology |
Epsilen Bio Srl
Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Epsilen Bio SRL operates as a biotechnology company. It develops novel therapies based on epigenetic silencing. The company was founded by Angelo Lombardo and Luigi Naldini in December 2019 and is headquartered in Milan, Italy. | Health Technology |
European Society of Gene & Cell Therapy | |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Health Technology |
- Stock Market
- Insiders
- Luigi Naldini
- Experience